Human heterozygous female carriers of TAF1 variants demonstrate a spectrum of phenotypes from asymptomatic to dystonia–parkinsonism features (Giovenino et al., 2023; Gudmundsson et al., 2019; Lee et al., 2011; Vianna et al., 2020). This evidence concerns the gene TAF1 and Parkinson disease.